Piracetam PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Piracetam PCD pharma franchise company offering 15 Piracetam formulations across Injection, Syrup, Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.
What is Piracetam?
Piracetam is a cyclic derivative of GABA and the prototype of the racetam class. Its mechanism is not fully established, but it is understood to modulate neuronal and erythrocyte membrane fluidity, improve microcirculation and influence cholinergic and glutamatergic neurotransmission. Clinically it is prescribed as an adjunct in cortical myoclonus and in cognitive and cerebrovascular disorders. It is a prescription-only medicine and must be initiated by a physician. See the compound record on PubChem.
Piracetam Range Available for Franchise
Our Piracetam portfolio comprises 15 formulations available in the following dosage forms: Injection, Syrup, Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Piracetam price list and stock position.
Therapeutic Applications of Piracetam
Piracetam is used as add-on therapy in cortical myoclonus, and in the supportive management of cognitive decline, post-stroke recovery, vertigo of central origin and dyslexia in children (as an adjunct alongside speech and language therapy). Prescriptions come from neurologists, neurosurgeons, psychiatrists, geriatricians and consulting physicians. Cafoli's range spans injection for acute hospital use and tablets and syrup for continuation therapy.
Why Piracetam is a High-Potential Molecule for Distributors
The commercial logic for piracetam rests on the continuum of care it covers. The injection is used in the acute hospital phase — post-stroke, post-head-injury, myoclonus — and the same patient then moves to tablets or syrup for months of continuation therapy, so a distributor stocking all three forms captures both the institutional order and the retail follow-on from the same prescription. India's ageing population and rising stroke burden keep the neurology segment growing, and paediatric syrup adds a second, distinct prescriber base. With 15 formulations, this molecule alone can carry a substantial part of a neuro-focused franchise portfolio.
Why Choose Cafoli Lifecare for Your Piracetam Franchise
Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.
References
- PubChem — Piracetam compound record (NIH / NCBI)
- MedlinePlus — Piracetam drug information (US National Library of Medicine)
- PubMed — clinical literature on Piracetam
Our formulations of Piracetam find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: